Alphabet Soup - Biomarker testing for colon and rectal cancer patients - KRAS, RAS
Carsten Bokemeyer*
KRAS status and efficacy in the first- line treatment of patients with mCRC treated with FOLFOX with or without cetuximab: The OPUS experience Carsten.
Www.OncologyEducation.ca KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI.
